Go Pro

Quanterix (QTRX) Financials

Quanterix logo
$4.16 -0.17 (-4.02%)
As of 10:14 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Quanterix

Annual Income Statements for Quanterix

This table shows Quanterix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-28 -31 -32 -41 -32 -56 -100 -28 -39 -107
Consolidated Net Income / (Loss)
-23 -27 -32 -41 -32 -56 -100 -28 -39 -107
Net Income / (Loss) Continuing Operations
-23 -27 -32 -41 -32 -56 -100 -28 -39 -107
Total Pre-Tax Income
-23 -27 -32 -41 -32 -56 -99 -28 -38 -112
Total Operating Income
-22 -26 -32 -42 -32 -57 -104 -46 -53 -126
Total Gross Profit
7.75 9.99 18 27 48 65 45 74 83 65
Total Revenue
18 23 38 57 86 111 106 122 137 139
Operating Revenue
18 23 38 57 86 111 106 122 137 139
Total Cost of Revenue
9.84 13 20 30 38 46 60 48 54 74
Operating Cost of Revenue
9.84 13 20 30 38 46 60 48 54 74
Total Operating Expenses
29 36 49 68 80 121 150 120 136 191
Selling, General & Admin Expense
12 20 34 52 60 93 92 89 102 138
Research & Development Expense
17 16 16 16 20 28 27 26 31 36
Other Operating Expenses / (Income)
- - - - 0.00 0.00 1.41 3.71 3.02 0.84
Restructuring Charge
- - - - 0.00 0.00 30 1.33 0.00 16
Total Other Income / (Expense), net
-1.46 -1.01 0.04 0.62 -0.32 0.94 4.85 18 15 13
Interest Expense
1.30 0.95 -0.05 -0.63 0.27 0.40 -5.13 -16 -15 -8.57
Other Income / (Expense), net
-0.16 -0.06 -0.01 -0.01 -0.05 1.34 -0.28 2.52 -0.14 4.70
Income Tax Expense
0.00 0.00 0.03 -0.19 -0.38 -0.04 0.16 0.72 0.43 -5.12
Basic Earnings per Share
($12.89) ($8.30) ($1.43) ($1.63) ($1.07) ($1.54) ($2.69) ($0.75) ($1.00) ($2.51)
Weighted Average Basic Shares Outstanding
2.14M 3.76M 21.99M 25.09M 29.59M 36.00M 36.99M 37.59M 38.37M 42.64M
Diluted Earnings per Share
($12.89) ($8.30) ($1.43) ($1.63) ($1.07) ($1.54) ($2.69) ($0.75) ($1.00) ($2.51)
Weighted Average Diluted Shares Outstanding
2.14M 3.76M 21.99M 25.09M 29.59M 36.00M 36.99M 37.59M 38.37M 42.64M
Weighted Average Basic & Diluted Shares Outstanding
2.14M 3.76M 21.99M 25.09M 29.59M 36.85M 37.25M 38.06M 38.78M 46.94M

Quarterly Income Statements for Quanterix

This table shows Quanterix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-6.72 -8.81 -11 -7.39 -8.35 -12 -21 -30 -34 -23 -18
Consolidated Net Income / (Loss)
-6.72 -8.81 -11 -7.39 -8.35 -12 -21 -30 -34 -23 -18
Net Income / (Loss) Continuing Operations
-6.72 -8.81 -11 -7.39 -8.35 -12 -21 -30 -34 -23 -18
Total Pre-Tax Income
-6.51 -8.67 -11 -7.27 -8.21 -12 -23 -30 -36 -23 -18
Total Operating Income
-13 -14 -15 -11 -12 -15 -26 -37 -37 -25 -41
Total Gross Profit
19 19 19 22 20 22 15 11 17 20 16
Total Revenue
32 32 32 34 36 35 30 24 40 44 36
Operating Revenue
32 32 32 34 36 35 30 24 40 44 36
Total Cost of Revenue
12 12 14 12 16 13 15 13 23 24 21
Operating Cost of Revenue
12 12 14 12 16 13 15 13 23 24 21
Total Operating Expenses
32 33 34 33 32 37 41 48 54 45 57
Selling, General & Admin Expense
24 23 26 24 23 29 31 31 39 35 30
Research & Development Expense
7.74 7.21 6.74 8.17 8.10 8.07 10 9.08 8.01 8.80 7.32
Impairment Charge
- - - - - - 0.00 - - - 20
Total Other Income / (Expense), net
6.30 4.95 4.17 3.67 3.54 3.13 2.95 7.01 1.27 2.04 24
Interest Expense
-4.19 -4.32 -3.95 -3.68 -3.54 -3.49 -3.27 -2.69 -1.45 -1.16 -0.89
Other Income / (Expense), net
2.11 0.63 0.23 -0.01 0.01 -0.36 -0.32 4.32 -0.18 0.88 23
Income Tax Expense
0.20 0.14 0.18 0.12 0.15 -0.01 -2.91 -0.07 -2.48 0.35 -0.01
Basic Earnings per Share
($0.18) ($0.23) ($0.29) ($0.19) ($0.22) ($0.30) ($0.53) ($0.77) ($0.73) ($0.48) ($0.37)
Weighted Average Basic Shares Outstanding
37.66M 37.59M 38.13M 38.34M 38.45M 38.37M 38.72M 38.89M 46.06M 42.64M 46.98M
Diluted Earnings per Share
($0.18) ($0.23) ($0.29) ($0.19) ($0.22) ($0.30) ($0.53) ($0.77) ($0.73) ($0.48) ($0.37)
Weighted Average Diluted Shares Outstanding
37.66M 37.59M 38.13M 38.34M 38.45M 38.37M 38.72M 38.89M 46.06M 42.64M 46.98M
Weighted Average Basic & Diluted Shares Outstanding
37.83M 38.06M 38.27M 38.38M 38.52M 38.78M 38.83M 46.47M 46.71M 46.94M 47.11M

Annual Cash Flow Statements for Quanterix

This table details how cash moves in and out of Quanterix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
27 50 -34 65 72 217 -57 -165 -117 -28
Net Cash From Operating Activities
-18 -22 -29 -26 -23 -48 -49 -19 -35 -77
Net Cash From Continuing Operating Activities
-18 -22 -29 -26 -23 -48 -49 -19 -35 -77
Net Income / (Loss) Continuing Operations
-23 -27 -32 -41 -32 -56 -100 -28 -39 -107
Consolidated Net Income / (Loss)
-23 -27 -32 -41 -32 -56 -100 -28 -39 -107
Depreciation Expense
0.44 0.48 1.35 3.01 4.31 4.88 5.41 6.28 6.46 16
Amortization Expense
- - 0.00 0.61 0.72 0.50 0.72 0.05 -4.94 1.00
Non-Cash Adjustments To Reconcile Net Income
3.91 2.50 5.04 7.11 11 17 41 19 21 26
Changes in Operating Assets and Liabilities, net
1.08 1.94 -3.58 3.88 -7.94 -14 4.30 -15 -19 -13
Net Cash From Investing Activities
-0.83 -1.13 -5.45 -25 -0.63 -6.40 -11 -148 -82 50
Net Cash From Continuing Investing Activities
-0.83 -1.13 -5.45 -25 -0.63 -6.40 -11 -148 -82 50
Purchase of Property, Plant & Equipment
-0.53 -1.13 -1.52 -11 -3.93 -14 -12 -3.84 -3.37 -2.61
Acquisitions
-0.30 - -3.80 -15 - - - 0.00 0.00 -93
Purchase of Investments
0.00 - -0.15 - - 0.00 0.00 -176 -296 -70
Sale and/or Maturity of Investments
- - - - - 0.00 0.00 31 217 216
Net Cash From Financing Activities
46 73 -0.08 116 96 271 2.31 2.69 0.46 -0.71
Net Cash From Continuing Financing Activities
46 73 -0.08 116 96 271 2.31 2.69 0.46 -0.71
Issuance of Common Equity
45 8.42 0.00 0.88 92 8.82 2.31 2.89 3.07 0.74
Other Financing Activities, net
0.23 0.23 1.87 2.82 4.02 0.00 0.00 -0.20 -2.61 -1.45

Quarterly Cash Flow Statements for Quanterix

This table details how cash moves in and out of Quanterix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-128 -27 -129 1.70 -18 28 19 56 -94 -8.53 6.39
Net Cash From Operating Activities
-3.79 -6.19 -20 -4.95 -5.75 -4.30 -14 -5.66 -41 -16 -18
Net Cash From Continuing Operating Activities
-3.79 -6.19 -20 -4.95 -5.75 -4.30 -14 -5.66 -41 -16 -18
Net Income / (Loss) Continuing Operations
-7.37 -8.81 -11 -7.39 -8.35 -12 -21 -30 -34 -23 -18
Consolidated Net Income / (Loss)
-7.37 -8.81 -11 -7.39 -8.35 -12 -21 -30 -34 -23 -18
Depreciation Expense
2.00 1.43 1.52 1.60 1.62 1.72 2.19 2.00 5.43 6.23 5.60
Amortization Expense
-0.97 0.02 -1.18 -1.60 -1.17 -0.99 -0.42 -0.30 0.92 0.80 0.65
Non-Cash Adjustments To Reconcile Net Income
4.62 5.08 5.39 5.76 4.35 5.13 5.10 11 7.20 2.05 11
Changes in Operating Assets and Liabilities, net
-2.06 -3.91 -15 -3.33 -2.19 1.47 -0.26 11 -21 -2.40 -18
Net Cash From Investing Activities
-126 -21 -109 6.98 -12 32 33 62 -53 8.44 25
Net Cash From Continuing Investing Activities
-126 -21 -109 6.98 -12 32 33 62 -53 8.44 25
Purchase of Property, Plant & Equipment
-1.09 -1.96 -0.51 -1.60 -0.85 -0.41 -1.26 -0.78 -0.68 0.10 -0.09
Acquisitions
- - 0.00 - - - -9.00 0.04 -84 - 0.00
Purchase of Investments
-125 -50 -138 -51 -82 -25 -30 0.00 -15 -24 0.00
Sale and/or Maturity of Investments
- 31 29 60 70 57 73 63 48 32 25
Net Cash From Financing Activities
1.80 0.20 0.60 -0.33 0.14 0.04 0.09 -0.43 0.15 -0.52 -0.77
Net Cash From Continuing Financing Activities
1.80 0.20 0.60 -0.33 0.14 0.04 0.09 -0.43 0.15 -0.52 -0.77
Issuance of Common Equity
1.86 0.26 2.04 0.38 0.58 0.07 0.67 - 0.26 -0.19 0.34
Other Financing Activities, net
-0.06 -0.06 -1.44 -0.71 -0.43 -0.03 -0.58 -0.43 -0.11 -0.33 -1.11

Annual Balance Sheets for Quanterix

This table presents Quanterix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
92 68 170 271 502 434 429 407 419
Total Current Assets
89 59 133 220 449 382 382 364 212
Cash & Equivalents
80 44 109 182 396 339 174 57 30
Short-Term Investments
- - - - - 0.00 147 232 88
Accounts Receivable
5.60 6.79 11 17 24 19 25 32 30
Inventories, net
3.57 5.95 10 15 22 17 26 33 55
Prepaid Expenses
0.40 2.33 2.14 5.98 6.51 6.80 9.23 9.56 9.29
Plant, Property, & Equipment, net
1.87 2.92 12 14 18 20 18 17 24
Total Noncurrent Assets
0.65 5.19 25 38 35 32 29 26 183
Goodwill
0.00 1.31 9.35 10 9.63 - - 0.00 26
Intangible Assets
0.00 2.35 14 14 11 7.52 6.03 4.03 132
Other Noncurrent Operating Assets
0.65 1.54 1.58 13 14 25 23 22 25
Total Liabilities & Shareholders' Equity
92 68 170 271 502 434 429 407 419
Total Liabilities
26 27 41 65 61 76 79 76 123
Total Current Liabilities
20 18 20 40 37 31 39 42 75
Accounts Payable
3.55 5.11 5.78 6.80 9.21 3.84 5.05 6.95 14
Accrued Expenses
3.56 3.13 2.50 4.85 6.49 5.15 6.06 8.85 18
Current Deferred Revenue
4.94 5.44 4.70 5.42 6.36 8.64 9.47 8.83 21
Current Employee Benefit Liabilities
2.62 4.45 6.57 11 13 11 14 13 15
Other Current Liabilities
- - 0.22 4.29 1.67 2.69 4.24 4.76 7.92
Total Noncurrent Liabilities
6.20 8.42 21 25 24 44 40 34 48
Noncurrent Deferred Revenue
1.71 0.52 0.47 0.58 1.10 1.42 1.23 1.07 5.83
Other Noncurrent Operating Liabilities
0.14 0.28 13 - 22 43 38 33 42
Commitments & Contingencies
0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
66 41 129 206 441 358 350 330 296
Total Preferred & Common Equity
66 41 129 206 441 358 350 330 296
Total Common Equity
66 41 129 206 441 358 350 330 296
Common Stock
210 217 345 451 746 764 783 803 874
Retained Earnings
-144 -176 -216 -248 -305 -403 -432 -470 -577
Accumulated Other Comprehensive Income / (Loss)
- - -0.15 2.43 0.44 -2.54 -1.67 -3.08 -0.72

Quarterly Balance Sheets for Quanterix

This table presents Quanterix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
429 414 416 411 397 376 444 367
Total Current Assets
381 369 370 367 335 322 233 186
Cash & Equivalents
201 45 47 29 77 133 38 36
Short-Term Investments
126 257 250 264 190 128 97 63
Accounts Receivable
24 29 32 31 28 24 33 27
Inventories, net
20 29 33 33 31 30 55 51
Prepaid Expenses
9.27 9.52 8.67 9.38 8.84 7.25 10 8.73
Plant, Property, & Equipment, net
18 17 18 18 16 16 26 21
Total Noncurrent Assets
31 27 27 26 45 38 185 160
Goodwill
- - - - 6.57 - 23 27
Intangible Assets
6.00 5.34 4.98 4.78 17 16 135 109
Other Noncurrent Operating Assets
25 22 22 22 22 21 26 24
Total Liabilities & Shareholders' Equity
429 414 416 411 397 376 444 367
Total Liabilities
76 71 75 72 80 83 130 85
Total Current Liabilities
35 33 38 36 40 48 77 50
Accounts Payable
4.79 3.98 7.27 6.38 6.73 9.12 11 8.66
Accrued Expenses
6.67 6.98 6.65 6.59 13 15 25 8.28
Current Deferred Revenue
9.83 10 10 8.98 9.10 9.43 21 15
Current Employee Benefit Liabilities
9.78 7.20 9.57 9.86 6.31 9.11 13 9.85
Other Current Liabilities
4.09 4.37 4.52 4.64 4.94 5.15 8.41 7.93
Total Noncurrent Liabilities
41 38 37 36 40 35 52 35
Noncurrent Deferred Revenue
1.13 0.93 0.93 0.88 1.10 1.06 7.34 2.80
Other Noncurrent Operating Liabilities
39 37 36 35 39 34 44 32
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
353 343 341 339 316 292 315 282
Total Preferred & Common Equity
353 343 341 339 316 292 315 282
Total Common Equity
353 343 341 339 316 292 315 282
Common Stock
779 789 794 799 809 814 869 878
Retained Earnings
-422 -443 -450 -458 -491 -521 -554 -595
Accumulated Other Comprehensive Income / (Loss)
-3.21 -2.95 -3.07 -1.41 -1.82 -0.93 -0.82 -1.01

Annual Metrics And Ratios for Quanterix

This table displays calculated financial ratios and metrics derived from Quanterix's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 22,197,779.00 28,014,764.00 31,668,184.00 36,648,018.00 37,054,705.00 37,829,746.00 - 46,710,797.00
DEI Adjusted Shares Outstanding
0.00 0.00 22,197,779.00 28,014,764.00 31,668,184.00 36,648,018.00 37,054,705.00 37,829,746.00 - 46,710,797.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -1.42 -1.46 -1.00 -1.52 -2.69 -0.75 - -2.29
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 30.08% 64.52% 50.76% 52.25% 27.99% -4.55% 15.96% 12.30% 1.07%
EBITDA Growth
0.00% -19.39% -18.05% -25.77% 29.98% -87.23% -97.62% 62.25% -37.91% -102.99%
EBIT Growth
0.00% -19.17% -21.06% -31.86% 23.98% -74.44% -89.45% 58.41% -21.34% -129.07%
NOPAT Growth
0.00% -19.78% -21.32% -31.85% 24.08% -78.95% -84.47% 55.89% -14.41% -138.60%
Net Income Growth
0.00% -16.60% -16.72% -29.36% 22.71% -76.18% -79.26% 71.52% -35.89% -178.09%
EPS Growth
0.00% 35.61% 82.77% -13.99% 34.36% -43.93% -74.68% 72.12% -33.33% -151.00%
Operating Cash Flow Growth
0.00% -24.60% -29.92% 8.82% 10.78% -103.81% -2.08% 61.22% -86.56% -119.65%
Free Cash Flow Firm Growth
0.00% 0.00% -123.52% -69.04% 5.72% 38.95% -59.25% 12.69% -17.96% -357.03%
Invested Capital Growth
0.00% 0.00% 196.05% 537.83% 99.17% -17.78% -56.86% 49.20% 42.89% 333.81%
Revenue Q/Q Growth
0.00% 0.00% 12.86% 9.75% 13.41% 3.91% -4.06% 4.71% 2.87% 6.68%
EBITDA Q/Q Growth
0.00% 0.00% -7.63% -2.65% 4.71% -18.66% -4.99% 18.38% 4.97% -2.42%
EBIT Q/Q Growth
0.00% 0.00% -7.96% -5.27% 4.73% -17.43% -3.99% 15.03% 6.22% -7.80%
NOPAT Q/Q Growth
0.00% 0.00% -7.94% -5.24% 4.69% -16.24% -4.64% 14.43% 7.26% -8.64%
Net Income Q/Q Growth
0.00% 0.00% -6.60% -4.15% 3.48% -16.99% -1.46% 24.32% 6.82% -12.01%
EPS Q/Q Growth
0.00% 0.00% -815.00% 0.00% 0.00% 0.00% -1.13% 25.00% 8.26% -7.73%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -14.82% 12.01% 28.23% -44.48% 10.76% -12.55% 5.24% -18.65%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 4.31% -35.58% 48.79% 34.67% -623.11% 17.36% -4.04%
Invested Capital Q/Q Growth
0.00% 0.00% 10.59% -11.07% 24.29% -34.55% -73.05% 11.67% -9.79% -1.51%
Profitability Metrics
- - - - - - - - - -
Gross Margin
44.06% 43.66% 47.69% 47.30% 55.78% 58.59% 42.99% 60.66% 60.47% 46.77%
EBITDA Margin
-121.87% -111.86% -80.26% -66.96% -30.79% -45.05% -93.27% -30.36% -37.28% -74.87%
Operating Margin
-123.46% -113.69% -83.84% -73.32% -36.57% -51.12% -98.81% -37.58% -38.29% -90.39%
EBIT Margin
-124.40% -113.96% -83.86% -73.34% -36.62% -49.91% -99.07% -35.53% -38.39% -87.00%
Profit (Net Income) Margin
-131.78% -118.12% -83.80% -71.91% -36.50% -50.24% -94.36% -23.17% -28.04% -77.14%
Tax Burden Percent
100.00% 100.00% 100.08% 99.54% 98.82% 99.94% 100.17% 102.60% 101.14% 95.44%
Interest Burden Percent
105.93% 103.65% 99.85% 98.49% 100.86% 100.73% 95.09% 63.57% 72.22% 92.91%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% -185.34% -54.41% -80.26% -229.23% -134.63% -105.91% -80.47%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% -168.45% -46.98% -74.43% -221.99% -135.79% -105.36% -71.01%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 137.26% 35.57% 63.09% 204.30% 126.62% 94.58% 46.22%
Return on Equity (ROE)
0.00% -41.02% -58.98% -48.07% -18.84% -17.17% -24.93% -8.01% -11.33% -34.25%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -722.66% -331.12% -120.71% -60.75% -149.78% -174.11% -141.23% -205.54%
Operating Return on Assets (OROA)
0.00% -28.40% -39.60% -35.03% -14.35% -14.29% -22.36% -10.09% -12.63% -29.28%
Return on Assets (ROA)
0.00% -29.44% -39.57% -34.35% -14.30% -14.38% -21.30% -6.58% -9.23% -25.97%
Return on Common Equity (ROCE)
0.00% -41.02% -58.98% -48.07% -18.84% -17.17% -24.93% -8.01% -11.33% -34.25%
Return on Equity Simple (ROE_SIMPLE)
0.00% -41.02% -76.80% -31.71% -15.30% -12.60% -27.82% 0.00% -11.67% 0.00%
Net Operating Profit after Tax (NOPAT)
-15 -18 -22 -29 -22 -40 -73 -32 -37 -88
NOPAT Margin
-86.42% -79.58% -58.69% -51.33% -25.60% -35.79% -69.17% -26.31% -26.80% -63.27%
Net Nonoperating Expense Percent (NNEP)
0.00% -25.08% -17.65% -16.89% -7.43% -5.83% -7.23% 1.16% -0.56% -9.46%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -8.97% -20.39% -9.20% -11.16% -29.72%
Cost of Revenue to Revenue
55.94% 56.34% 52.31% 52.70% 44.22% 41.41% 57.01% 39.34% 39.53% 53.23%
SG&A Expenses to Revenue
70.89% 86.07% 89.53% 92.09% 68.99% 84.04% 87.04% 72.82% 73.95% 99.36%
R&D to Revenue
96.63% 71.28% 42.00% 28.54% 23.36% 25.67% 25.41% 21.30% 22.62% 25.86%
Operating Expenses to Revenue
167.52% 157.35% 131.53% 120.63% 92.35% 109.71% 141.80% 98.24% 98.76% 137.15%
Earnings before Interest and Taxes (EBIT)
-22 -26 -32 -42 -32 -55 -105 -43 -53 -121
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-21 -26 -30 -38 -27 -50 -98 -37 -51 -104
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 9.90 5.15 7.14 3.52 1.43 2.96 1.24 1.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 10.86 6.30 8.09 3.69 1.46 3.01 1.26 2.16
Price to Revenue (P/Rev)
0.00 0.00 10.80 11.67 17.05 14.06 4.86 8.45 2.98 2.14
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 86.79 20.63 24.41 26.02 9.09 24.90 2.94 1.01
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 9.82 9.88 15.29 10.47 1.65 5.83 0.88 1.29
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.14 0.19 0.06 0.14 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.07 0.19 0.06 0.11 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -1.07 -1.00 -0.81 -0.76 -0.85 -0.92 -0.93 -0.90 -0.65
Leverage Ratio
0.00 1.39 1.49 1.40 1.32 1.19 1.17 1.22 1.23 1.32
Compound Leverage Factor
0.00 1.44 1.49 1.38 1.33 1.20 1.11 0.77 0.89 1.23
Debt to Total Capital
0.00% 12.47% 15.66% 5.62% 12.54% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 6.69% 0.00% 0.06% 3.26% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 5.78% 15.66% 5.57% 9.29% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 87.53% 84.34% 94.38% 87.46% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 -0.37 -0.25 -0.20 -1.11 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 2.75 1.22 2.67 5.72 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 -0.17 -0.25 -0.20 -0.82 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 -0.52 -0.35 -0.26 -1.34 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 3.86 1.67 3.49 6.88 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 -0.24 -0.35 -0.26 -0.99 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 0.00 5.30 8.16 13.06 15.38 3.19 7.40 2.45 -0.71
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 4.53 3.28 6.69 5.52 12.14 12.17 9.80 8.66 2.84
Quick Ratio
0.00 4.33 2.83 6.05 4.99 11.37 11.41 8.89 7.65 1.98
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -14 -31 -52 -49 -30 -48 -42 -49 -224
Operating Cash Flow to CapEx
-3,373.00% -1,952.83% -1,910.91% -241.42% -594.53% -348.23% -418.56% -490.73% -1,044.06% -2,956.97%
Free Cash Flow to Firm to Interest Expense
0.00 -14.48 0.00 0.00 -179.67 -74.31 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-13.67 -23.25 0.00 0.00 -85.59 -118.17 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-14.07 -24.44 0.00 0.00 -99.98 -152.10 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.25 0.47 0.48 0.39 0.29 0.23 0.28 0.33 0.34
Accounts Receivable Turnover
0.00 4.09 6.07 6.41 6.15 5.40 4.93 5.51 4.78 4.47
Inventory Turnover
0.00 3.61 4.14 3.64 3.02 2.47 3.07 2.23 1.84 1.69
Fixed Asset Turnover
0.00 12.21 15.69 7.58 6.65 6.94 5.59 6.49 7.84 6.81
Accounts Payable Turnover
0.00 3.63 4.54 5.49 6.07 5.72 9.22 10.84 9.05 7.21
Days Sales Outstanding (DSO)
0.00 89.34 60.09 56.93 59.35 67.63 74.03 66.26 76.44 81.61
Days Inventory Outstanding (DIO)
0.00 101.14 88.23 100.16 120.98 147.67 118.78 163.33 197.89 216.07
Days Payable Outstanding (DPO)
0.00 100.60 80.31 66.46 60.09 63.81 39.57 33.68 40.32 50.65
Cash Conversion Cycle (CCC)
0.00 89.88 68.01 90.63 120.24 151.49 153.23 195.92 234.00 247.03
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 -4.43 4.26 27 54 44 19 29 41 177
Invested Capital Turnover
0.00 -10.32 -430.08 3.61 2.13 2.24 3.31 5.12 3.95 1.27
Increase / (Decrease) in Invested Capital
0.00 -4.43 8.69 23 27 -9.62 -25 9.44 12 137
Enterprise Value (EV)
0.00 0.00 370 560 1,321 1,157 174 713 120 179
Market Capitalization
0.00 0.00 406 662 1,473 1,554 513 1,034 410 297
Book Value per Share
$0.00 $17.53 $1.85 $4.59 $6.51 $12.03 $9.66 $9.25 $8.57 $6.33
Tangible Book Value per Share
$0.00 $17.53 $1.69 $3.75 $5.75 $11.48 $9.46 $9.09 $8.46 $2.95
Total Capital
0.00 75 49 136 236 441 358 350 330 296
Total Debt
0.00 9.38 7.62 7.66 30 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 4.35 7.62 7.59 22 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -70 -37 -101 -152 -396 -339 -321 -289 -118
Capital Expenditures (CapEx)
0.53 1.13 1.50 11 3.93 14 12 3.84 3.37 2.61
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -5.11 -3.06 3.75 5.89 16 11 22 32 19
Debt-free Net Working Capital (DFNWC)
0.00 75 41 113 187 412 350 343 322 137
Net Working Capital (NWC)
0.00 70 41 113 180 412 350 343 322 137
Net Nonoperating Expense (NNE)
7.98 8.82 9.45 12 9.42 16 27 -3.84 1.70 19
Net Nonoperating Obligations (NNO)
0.00 -70 -37 -101 -152 -396 -339 -321 -289 -118
Total Depreciation and Amortization (D&A)
0.44 0.48 1.35 3.62 5.03 5.38 6.12 6.33 1.52 17
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -22.33% -8.13% 6.61% 6.82% 14.03% 10.84% 17.81% 23.62% 13.87%
Debt-free Net Working Capital to Revenue
0.00% 326.02% 109.94% 199.00% 217.04% 372.64% 331.85% 280.39% 234.02% 98.99%
Net Working Capital to Revenue
0.00% 304.00% 109.94% 198.87% 208.16% 372.64% 331.85% 280.39% 234.02% 98.99%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($12.89) ($8.30) ($1.43) ($1.63) $0.00 ($1.60) ($2.61) $0.00 ($1.00) ($2.51)
Adjusted Weighted Average Basic Shares Outstanding
2.14M 3.76M 22.46M 28.23M 36.27M 36.00M 36.99M 0.00 38.37M 42.64M
Adjusted Diluted Earnings per Share
($12.89) ($8.30) ($1.43) ($1.63) $0.00 ($1.60) ($2.61) $0.00 ($1.00) ($2.51)
Adjusted Weighted Average Diluted Shares Outstanding
2.14M 3.76M 22.46M 28.23M 36.27M 36.00M 36.99M 0.00 38.37M 42.64M
Adjusted Basic & Diluted Earnings per Share
($12.89) ($8.30) ($1.43) ($1.63) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
2.14M 3.76M 21.99M 25.09M 29.59M 36.85M 37.25M 0.00 38.78M 46.94M
Normalized Net Operating Profit after Tax (NOPAT)
-15 -18 -22 -29 -22 -40 -52 -31 -37 -77
Normalized NOPAT Margin
-86.42% -79.58% -58.69% -51.33% -25.60% -35.79% -49.56% -25.55% -26.80% -55.34%
Pre Tax Income Margin
-131.78% -118.12% -83.73% -72.24% -36.94% -50.28% -94.21% -22.58% -27.72% -80.83%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-16.85 -27.41 0.00 0.00 -115.87 -136.93 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
-11.71 -19.14 0.00 0.00 -80.98 -98.18 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-17.26 -28.60 0.00 0.00 -130.27 -170.86 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
-12.11 -20.33 0.00 0.00 -95.38 -132.11 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 275.88% 0.00% 485.56% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Quanterix

This table displays calculated financial ratios and metrics derived from Quanterix's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
37,552,586.00 37,829,746.00 76,127,236.00 76,540,176.00 76,758,066.00 - 38,776,208.00 38,829,386.00 46,465,915.00 46,710,797.00 46,939,975.00
DEI Adjusted Shares Outstanding
37,552,586.00 37,829,746.00 76,127,236.00 76,540,176.00 76,758,066.00 - 38,776,208.00 38,829,386.00 46,465,915.00 46,710,797.00 46,939,975.00
DEI Earnings Per Adjusted Shares Outstanding
-0.18 -0.23 -0.15 -0.10 -0.11 - -0.53 -0.77 -0.72 -0.49 -0.37
Growth Metrics
- - - - - - - - - - -
Revenue Growth
18.44% 22.17% 12.69% 11.61% 13.48% 11.45% -5.40% -28.81% 12.34% 24.73% 20.05%
EBITDA Growth
72.47% 50.44% -65.86% -54.44% -16.75% -24.81% -70.80% -183.82% -175.79% -17.04% 51.07%
EBIT Growth
70.85% 46.13% -41.08% -19.01% -9.77% -16.44% -78.72% -199.32% -219.36% -57.82% 30.89%
NOPAT Growth
65.01% 44.45% -43.29% -21.74% 8.28% -8.46% -73.95% -239.06% -217.71% -67.59% -56.88%
Net Income Growth
80.85% 58.92% -53.46% -33.08% -24.37% -31.94% -83.68% -306.29% -301.26% -98.80% 14.45%
EPS Growth
81.05% 60.34% -52.63% -26.67% -22.22% -30.43% -82.76% -305.26% -231.82% -60.00% 30.19%
Operating Cash Flow Growth
73.96% -39.81% -105.25% -796.34% -51.72% 30.52% 31.12% -14.22% -617.75% -282.24% -30.38%
Free Cash Flow Firm Growth
226.82% -333.25% -139.97% -146.67% -176.31% -19.22% -10.07% 48.22% -476.21% -580.40% -512.14%
Invested Capital Growth
-64.00% 49.20% 48.18% 70.04% 76.89% 42.89% 19.44% -28.77% 297.33% 333.81% 269.32%
Revenue Q/Q Growth
1.71% -0.03% 1.64% 7.22% 4.17% -1.82% -13.73% -19.31% 64.38% 9.00% -16.97%
EBITDA Q/Q Growth
-26.61% -19.25% -26.45% 24.93% -3.14% -27.48% -73.04% -24.74% -0.23% 45.90% 27.66%
EBIT Q/Q Growth
-10.12% -21.43% -14.93% 26.66% -7.23% -28.82% -76.40% -22.84% -14.42% 36.34% 22.76%
NOPAT Q/Q Growth
-33.96% -6.32% -11.31% 27.81% -7.37% -25.72% -78.52% -40.71% -0.61% 33.69% -67.11%
Net Income Q/Q Growth
-10.75% -31.22% -26.67% 33.83% -13.08% -39.21% -76.33% -46.38% -11.67% 31.03% 24.12%
EPS Q/Q Growth
-12.50% -27.78% -26.09% 34.48% -15.79% -36.36% -76.67% -45.28% 5.19% 34.25% 22.92%
Operating Cash Flow Q/Q Growth
-698.42% -63.46% -225.65% 75.45% -16.08% 25.14% -222.83% 59.28% -629.43% 60.13% -10.11%
Free Cash Flow Firm Q/Q Growth
-33.15% -151.82% -26.96% -6.90% -8.50% 19.04% -17.22% 49.72% -1,107.46% 4.40% -5.46%
Invested Capital Q/Q Growth
-0.73% 11.67% 44.78% 5.95% 3.27% -9.79% 21.02% -36.82% 476.04% -1.51% 3.03%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
61.50% 61.51% 57.84% 64.67% 56.27% 63.05% 48.92% 46.17% 42.77% 45.69% 42.75%
EBITDA Margin
-30.65% -36.57% -45.49% -31.85% -31.54% -40.95% -82.14% -126.97% -77.42% -38.42% -33.48%
Operating Margin
-40.58% -43.16% -47.27% -31.83% -32.80% -42.00% -86.92% -151.58% -92.77% -56.44% -113.59%
EBIT Margin
-33.90% -41.18% -46.56% -31.85% -32.79% -43.02% -87.97% -133.92% -93.21% -54.44% -50.64%
Profit (Net Income) Margin
-21.28% -27.93% -34.81% -21.49% -23.32% -33.07% -67.60% -122.62% -83.31% -52.71% -48.17%
Tax Burden Percent
103.12% 101.63% 101.64% 101.61% 101.77% 99.93% 87.56% 99.76% 93.11% 101.52% 99.96%
Interest Burden Percent
60.88% 66.75% 73.56% 66.39% 69.90% 76.92% 87.76% 91.79% 95.98% 95.38% 95.16%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-68.55% -154.61% -120.06% -82.75% -86.55% -116.19% -181.50% -354.91% -74.97% -50.25% -99.21%
ROIC Less NNEP Spread (ROIC-NNEP)
-69.27% -154.82% -119.89% -82.84% -86.51% -115.77% -180.78% -353.46% -71.51% -47.40% -105.44%
Return on Net Nonoperating Assets (RNNOA)
60.03% 144.36% 108.01% 74.54% 77.64% 103.93% 155.86% 311.48% 46.82% 30.86% 64.50%
Return on Equity (ROE)
-8.53% -10.24% -12.06% -8.21% -8.91% -12.26% -25.65% -43.43% -28.14% -19.39% -34.70%
Cash Return on Invested Capital (CROIC)
16.43% -174.11% -140.79% -157.29% -157.02% -141.23% -115.94% -133.90% -191.29% -205.54% -199.44%
Operating Return on Assets (OROA)
-9.05% -11.69% -13.94% -9.77% -10.45% -14.16% -29.45% -42.56% -28.38% -18.32% -19.24%
Return on Assets (ROA)
-5.68% -7.93% -10.42% -6.59% -7.43% -10.88% -22.63% -38.97% -25.37% -17.74% -18.30%
Return on Common Equity (ROCE)
-8.53% -10.24% -12.06% -8.21% -8.91% -12.26% -25.65% -43.43% -28.14% -19.39% -34.70%
Return on Equity Simple (ROE_SIMPLE)
-10.60% 0.00% -9.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-8.97 -9.53 -11 -7.66 -8.22 -10 -18 -26 -26 -17 -29
NOPAT Margin
-28.41% -30.21% -33.09% -22.28% -22.96% -29.40% -60.85% -106.10% -64.94% -39.51% -79.51%
Net Nonoperating Expense Percent (NNEP)
0.72% 0.22% -0.18% 0.09% -0.04% -0.42% -0.72% -1.45% -3.45% -2.84% 6.23%
Return On Investment Capital (ROIC_SIMPLE)
-2.54% -2.72% -3.09% -2.25% -2.43% -3.13% -5.83% -8.88% -8.29% -5.86% -10.26%
Cost of Revenue to Revenue
38.50% 38.49% 42.16% 35.33% 43.73% 36.95% 51.08% 53.83% 57.23% 54.31% 57.25%
SG&A Expenses to Revenue
74.62% 74.39% 81.20% 70.04% 63.97% 81.31% 102.75% 128.10% 97.09% 80.12% 81.75%
R&D to Revenue
24.52% 22.85% 21.03% 23.76% 22.63% 22.94% 33.09% 37.10% 19.91% 20.06% 20.11%
Operating Expenses to Revenue
102.09% 104.67% 105.11% 96.50% 89.08% 105.05% 135.84% 197.74% 135.39% 102.26% 156.33%
Earnings before Interest and Taxes (EBIT)
-11 -13 -15 -11 -12 -15 -27 -33 -38 -24 -18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-9.67 -12 -15 -11 -11 -14 -25 -31 -31 -17 -12
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.88 2.96 2.61 1.48 1.47 1.24 0.80 0.88 0.80 1.00 0.59
Price to Tangible Book Value (P/TBV)
2.93 3.01 2.65 1.51 1.49 1.26 0.86 0.94 1.62 2.16 1.13
Price to Revenue (P/Rev)
8.72 8.45 7.12 3.90 3.72 2.98 1.86 2.05 1.94 2.14 1.14
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
26.97 24.90 14.35 4.75 4.49 2.94 0.00 0.00 0.65 1.01 0.36
Enterprise Value to Revenue (EV/Rev)
5.92 5.83 4.72 1.61 1.52 0.88 0.00 0.00 0.91 1.29 0.46
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
86.88 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.87 -0.93 -0.90 -0.90 -0.90 -0.90 -0.86 -0.88 -0.65 -0.65 -0.61
Leverage Ratio
1.21 1.22 1.20 1.21 1.21 1.23 1.23 1.25 1.31 1.32 1.28
Compound Leverage Factor
0.73 0.81 0.88 0.81 0.85 0.94 1.08 1.15 1.26 1.26 1.21
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.16% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.16% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 99.84% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.32 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.66 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.00
Altman Z-Score
7.86 7.63 7.26 3.71 3.77 2.76 1.17 0.84 -0.14 0.06 -0.42
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
10.84 9.80 11.28 9.71 10.07 8.66 8.29 6.68 3.02 2.84 3.72
Quick Ratio
10.01 8.89 10.11 8.62 8.90 7.65 7.31 5.91 2.17 1.98 2.53
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
37 -19 -24 -26 -28 -23 -27 -13 -161 -154 -162
Operating Cash Flow to CapEx
-346.25% -315.44% -3,984.98% -309.63% -675.32% -1,044.17% -1,105.73% -727.80% -6,092.91% 0.00% -20,812.64%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.27 0.28 0.30 0.31 0.32 0.33 0.33 0.32 0.30 0.34 0.38
Accounts Receivable Turnover
5.51 5.51 4.86 4.61 4.85 4.78 4.72 4.55 4.06 4.47 5.27
Inventory Turnover
2.56 2.23 2.15 1.95 2.02 1.84 1.89 1.76 1.44 1.69 1.93
Fixed Asset Turnover
6.00 6.49 6.89 7.09 7.61 7.84 7.99 7.41 6.00 6.81 7.67
Accounts Payable Turnover
14.16 10.84 14.99 9.51 9.58 9.05 10.51 6.80 7.42 7.21 10.31
Days Sales Outstanding (DSO)
66.23 66.26 75.07 79.18 75.25 76.44 77.38 80.28 89.87 81.61 69.28
Days Inventory Outstanding (DIO)
142.78 163.33 169.54 187.58 180.61 197.89 193.42 207.34 254.25 216.07 188.70
Days Payable Outstanding (DPO)
25.77 33.68 24.35 38.40 38.11 40.32 34.72 53.68 49.19 50.65 35.42
Cash Conversion Cycle (CCC)
183.24 195.92 220.26 228.36 217.75 234.00 236.08 233.95 294.93 247.03 222.56
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
26 29 41 44 45 41 50 31 180 177 183
Invested Capital Turnover
2.41 5.12 3.63 3.71 3.77 3.95 2.98 3.34 1.15 1.27 1.25
Increase / (Decrease) in Invested Capital
-46 9.44 13 18 20 12 8.06 -13 135 137 133
Enterprise Value (EV)
691 713 595 209 204 120 -14 -2.96 118 179 66
Market Capitalization
1,019 1,034 897 506 497 410 252 258 252 297 165
Book Value per Share
$9.41 $9.25 $9.02 $8.90 $8.83 $8.57 $8.16 $7.53 $6.77 $6.33 $6.01
Tangible Book Value per Share
$9.25 $9.09 $8.88 $8.77 $8.71 $8.46 $7.56 $7.11 $3.36 $2.95 $3.12
Total Capital
353 350 343 341 339 330 316 292 315 296 282
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00
Net Debt
-328 -321 -302 -297 -294 -289 -267 -261 -134 -118 -99
Capital Expenditures (CapEx)
1.09 1.96 0.51 1.60 0.85 0.41 1.26 0.78 0.68 -0.10 0.09
Debt-free, Cash-free Net Working Capital (DFCFNWC)
18 22 35 36 37 32 28 13 21 19 37
Debt-free Net Working Capital (DFNWC)
346 343 337 332 331 322 295 274 156 137 136
Net Working Capital (NWC)
346 343 337 332 331 322 295 274 156 137 136
Net Nonoperating Expense (NNE)
-2.25 -0.72 0.55 -0.27 0.13 1.29 2.05 4.04 7.39 5.79 -11
Net Nonoperating Obligations (NNO)
-328 -321 -302 -297 -294 -289 -267 -261 -134 -118 -99
Total Depreciation and Amortization (D&A)
1.02 1.46 0.34 0.00 0.45 0.73 1.77 1.70 6.36 7.02 6.25
Debt-free, Cash-free Net Working Capital to Revenue
15.53% 17.81% 27.52% 27.40% 27.64% 23.62% 20.44% 10.13% 16.22% 13.87% 25.21%
Debt-free Net Working Capital to Revenue
295.94% 280.39% 267.19% 256.54% 247.00% 234.02% 217.12% 217.77% 119.76% 98.99% 93.68%
Net Working Capital to Revenue
295.94% 280.39% 267.19% 256.54% 247.00% 234.02% 217.12% 217.77% 119.76% 98.99% 93.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.21) ($0.23) $0.00 $0.00 ($0.22) ($0.30) ($0.53) ($0.77) ($0.73) ($0.48) ($0.37)
Adjusted Weighted Average Basic Shares Outstanding
37.66M 37.59M 0.00 0.00 38.45M 38.37M 38.72M 38.89M 46.06M 42.64M 46.98M
Adjusted Diluted Earnings per Share
($0.21) ($0.23) $0.00 $0.00 ($0.22) ($0.30) ($0.53) ($0.77) ($0.73) ($0.48) ($0.37)
Adjusted Weighted Average Diluted Shares Outstanding
37.66M 37.59M 0.00 0.00 38.45M 38.37M 38.72M 38.89M 46.06M 42.64M 46.98M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
37.83M 38.06M 0.00 0.00 38.52M 38.78M 38.83M 46.47M 46.71M 46.94M 47.11M
Normalized Net Operating Profit after Tax (NOPAT)
-8.97 -9.53 -11 -7.66 -8.22 -10 -18 -21 -21 -17 -15
Normalized NOPAT Margin
-28.41% -30.21% -33.09% -22.28% -22.96% -29.40% -60.85% -84.17% -52.56% -39.51% -41.38%
Pre Tax Income Margin
-20.64% -27.49% -34.25% -21.15% -22.92% -33.09% -77.20% -122.92% -89.47% -51.92% -48.19%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Quanterix (NASDAQ: QTRX) showed a mixed financial picture in Q1 2026, with a large cash reserve and meaningful investment income offset by weak core profitability and continued operating losses. Over the last several years, revenue has been uneven, expenses have remained elevated, and the company has relied on its balance sheet and investment portfolio to support operations.

What stands out in the latest quarter: Q1 2026 revenue fell to $36.4 million from $43.9 million in Q4 2025, but gross profit improved to $15.6 million as cost of revenue declined. The bigger issue remains operating leverage: Quanterix posted an operating loss of $41.4 million and a net loss of $17.5 million, even after $22.9 million in other income. Cash from operations was still negative at $18.1 million.

  • Quanterix ended Q1 2026 with strong liquidity, including $36.2 million in cash and $63.1 million in short-term investments.
  • Total current assets of $185.7 million were well above total current liabilities of $49.9 million, indicating solid short-term balance sheet coverage.
  • The company generated $25.4 million from sales and/or maturity of investments in Q1 2026, helping offset operating cash burn.
  • Gross profit improved sequentially to $15.6 million in Q1 2026 from $12.0 million in Q4 2025, helped by lower cost of revenue.
  • Cash and investments remain substantial, but they have declined sharply from the start of 2025 as the company funded losses and acquisitions.
  • Revenue has generally hovered in the $30 million to mid-$40 million range per quarter over the last four years, suggesting a stable but not fast-growing top line.
  • The company recorded a large impairment charge of $19.8 million in Q1 2026, which weighs on reported earnings quality.
  • Quanterix posted strong other income in Q1 2026, but much of it came from non-core sources rather than operating performance.
  • Core operations remain deeply unprofitable, with Q1 2026 operating expenses of $56.9 million versus $36.4 million in revenue.
  • Operating cash flow was negative in every quarter shown, including a $18.1 million outflow in Q1 2026 and a $16.4 million outflow in Q4 2025.
  • The company has a long history of net losses, including losses of $20.5 million in Q1 2025, $30.0 million in Q2 2025, $33.5 million in Q3 2025, and $23.1 million in Q4 2025.
  • SG&A spending remains heavy, and in several quarters it exceeded gross profit by a wide margin, limiting the path to profitability.
  • Retained earnings remain deeply negative at $594.8 million in Q1 2026, underscoring years of accumulated losses.

Trend summary: The most important trend is that Quanterix still has room to operate thanks to its cash and investments, but the business has not yet demonstrated consistent earnings power. Revenue has been relatively steady, yet operating costs, restructuring items, and occasional impairment charges continue to overwhelm gross profit. The balance sheet is currently a strength, but the company will need better operating efficiency or faster revenue growth to reduce reliance on investment income and balance sheet resources.

Bottom line: Quanterix does not appear to be in immediate liquidity distress, but the financial statements show a company still searching for durable profitability. For investors, the key question is whether management can convert its cash position and product base into sustained operating improvement before the cash hoard continues to shrink.

07/06/26 10:15 AM ETAI Generated. May Contain Errors.

Quanterix Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Quanterix's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Quanterix's net income appears to be on an upward trend, with a most recent value of -$107.15 million in 2025, rising from -$23.17 million in 2016. The previous period was -$38.53 million in 2024. See Quanterix's forecast for analyst expectations on what's next for the company.

Quanterix's total operating income in 2025 was -$125.54 million, based on the following breakdown:
  • Total Gross Profit: $64.96 million
  • Total Operating Expenses: $190.50 million

Over the last 9 years, Quanterix's total revenue changed from $17.59 million in 2016 to $138.90 million in 2025, a change of 689.9%.

Quanterix's total liabilities were at $123.04 million at the end of 2025, a 60.8% increase from 2024, and a 374.8% increase since 2017.

In the past 8 years, Quanterix's cash and equivalents has ranged from $29.84 million in 2025 to $396.47 million in 2021, and is currently $29.84 million as of their latest financial filing in 2025.

Over the last 9 years, Quanterix's book value per share changed from 0.00 in 2016 to 6.33 in 2025, a change of 633.1%.



Financial statements for NASDAQ:QTRX last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners